Evidence map›Paper›PMID 35117384›Full record

ArticleTranslational cancer research2020

Long-term survivors with immunotherapy in advanced NSCLC: is 'cure' within reach?

Sara Monteverdi, Emanuele Vita, Giulia Sartori, Miriam Grazia Ferrara, Ettore D'Argento, Giampaolo Tortora, Michele Milella, Emilio Bria, Sara Pilotto

Open access · diamondAbstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational cancer research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Effects of antibiotics on the anti-tumor efficacy of immune checkpoint inhibitor therapy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Sara MonteverdiU.O.C. Oncology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
Emanuele VitaMedical Oncology, Università Cattolica del Sacro Cuore, Roma, Italy.
Giulia SartoriU.O.C. Oncology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
Miriam Grazia FerraraMedical Oncology, Università Cattolica del Sacro Cuore, Roma, Italy.
Ettore D'ArgentoComprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.
Giampaolo TortoraMedical Oncology, Università Cattolica del Sacro Cuore, Roma, Italy.
Michele MilellaU.O.C. Oncology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
Emilio Bria *Medical Oncology, Università Cattolica del Sacro Cuore, Roma, Italy.
Sara Pilotto *U.O.C. Oncology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
Università Cattolica del Sacro Cuore · ITAzienda Ospedaliera Universitaria Integrata Verona · ITUniversity of Verona · ITAgostino Gemelli University Polyclinic · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35117384
PMCPMC8798740
OpenAlexW2997650482

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.